In this context, Zhang et al., developed recombinant magnetosomes functionalized with an anti-HER-2 affibody that showed high specificity only for the SKBR-3 HER-2+ BC model up to 24h after IV administration. The gene discussed is ERBB2; the disease is breast cancer.